发明申请
- 专利标题： CDC45L PEPTIDES AND VACCINES INCLUDING THE SAME
- 专利标题（中）： CDC45L肽和疫苗，包括它们
-
申请号： US13321812申请日： 2010-05-25
-
公开(公告)号： US20120164163A1公开(公告)日： 2012-06-28
- 发明人: Yasuharu Nishimura , Yusuke Tomita , Yusuke Nakamura , Takuya Tsunoda
- 申请人： Yasuharu Nishimura , Yusuke Tomita , Yusuke Nakamura , Takuya Tsunoda
- 国际申请： PCT/JP2010/003488 WO 20100525
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; C12N5/10 ; C12N5/02 ; A61P37/02 ; C12N1/21 ; C07H21/04 ; A61P35/00 ; A61K38/10 ; A61K38/08 ; C07K7/08 ; C07K7/06 ; C07K16/00 ; C12N5/00 ; C12N15/63
摘要：
The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 18, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of the present invention can be used for treating cancer.
公开/授权文献
- US08586547B2 CDC45L peptides and vaccines including the same 公开/授权日：2013-11-19
信息查询
